Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Prevalence of Coronary Vasospasm Using Coronary Reactivity Testing in Patients With Spontaneous Coronary Artery DissectionSolaru KW, Heupler F, Kim ESH et al. -
Characterization of lesions undergoing ischemia-driven revascularization after complete revascularization versus culprit lesion only in patients with STEMI and multivessel disease - A DANAMI-3-PRIMULTI substudyDe Backer O, Lønborg J, Helqvist S et al.
-
Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial InfarctionKH Cho , XY Han, and on behalf of the KAMIR-NIH Investigators.
-
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus StatementPB Shah, FGP Welt, E Mahmud et al.
-
4-Step Protocol for Disparities in STEMI Care and Outcomes in WomenCP Huded, M Johnson, UN Khot et al.
-
Early Natural History of Spontaneous Coronary Artery DissectionWaterbury TM, Tweet MS, Hayes SN et al.
-
Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized TrialsElgendy IY, Mahmoud AN, Kumbhani DJ et al.
-
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialValgimigli M, Frigoli E, MATRIX Investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
